Affordable Care Act Marketplace Prices Fall Amid Increasing Competition
Average premiums for insurance plans in the Affordable Care Act marketplaces have dropped by 1.8% this year, marking the third [...]
Regional Variations in Hospital Pricing Represent Potential Policy Target
The RAND Corporation recently published a report finding that, although hospitals’ commercial payer prices didn’t vary widely from Medicare prices, [...]
MArS Supplier Spotlight
Supplier Spotlight® highlights the unique skill sets and service offerings from organizations who are part of our CONNECTED COMMUNITY™. Below [...]
ICER Will Develop California State Unsupported Price Reports
The California Health Care Foundation (CHCF) has awarded The Institute for Clinical and Economic Review (ICER) a new grant to [...]
Study: High Prices May Not Translate to Better Care
The old adage “you get what you pay for” doesn’t neccesarily apply to healthcare, according to a recent study published [...]
Cost-Sharing has Unforeseen Consequences for Patients and Payers
Cost-sharing measures like co-pays, deductibles, and co-insurance are ostensibly intended to help reduce payer costs and have patients take ownership [...]
Drug Rebate Safe Harbor Protections Removed but Loopholes Still Remain
The Department of Health and Human Services (DHS) has nixed the “Safe Harbor” protections for pharma rebates to PBMs, according [...]
Congress Pursuing Price Setting Measures that May Not Benefit Patients
In a new PhRMA article, Nicole Longo argues that Congress is starting off the year on a wrong foot with [...]
Michigan Attorney General Seeks Investigation Regarding Eli Lilly’s Exorbitant Insulin Prices
The Michigan Attorney General has asked the courts to approve a formal investigation into Eli Lilly’s excessive insulin prices. The [...]
States Can Help Lower Medicine Costs for Patients
Medicine costs for patients have spiked in the past few years, especially for patients with deductibles who often pay the [...]
ICER Releases Draft Report on Plinabulin and Trilaciclib for Chemo-induced Neutropenia
The Institute for Clinical and Economic Review (ICER) has released its draft evidence report for the novel drugs plinabulin (BeyondSpring [...]
Market Competition Benefits from Price Regulation
In a new publication in the journal Health Affairs, authors Robert A. Berenson and Robert B. Murray make the case [...]
AJMC Study: Projected US Savings from Biosimilars, 2021-2025
In a recent study published in the American Journal of Managed Care, researchers Andrew Mulcahy, PhD, and colleagues project US [...]
Forbes: 2022 Economy, Politics, and Drug Pricing Legislation Predictions
In a Forbes piece published early this month, Joshua Cohen makes predictions about the economy, politics, and drug pricing reform [...]
Pfizer, Gilead, and Vertex Raise Prices on Blockbuster Drugs
Major pharmaceutical companies are hiking prices on their blockbuster drugs for 2022. Pfizer is spiking the price of its cancer [...]
Cancer Patients Save Money on Medication Due to ‘Skinny Labeling’
A new study finds that applying a ‘skinny label’ to the generic cancer drug Gleevec made the medicine available for [...]
China National Insurance System and Pharma Reach Pricing Agreement
Pharma and the Chinese government have reached an agreement resulting in price cuts averaging over 60% for Chinese citizens. The [...]
Prior Authorization Examined from the Health Reporter’s Perspective
Prior authorization is a point of conflict between doctors and insurers in the United States, often dragging patients along in [...]
Integrated Prescription Discount Card Pricing Plan from Express Scripts
The new Right Price offering by Express Scripts automatically applies prescription discount card savings into the price at the point [...]
Company Formerly Owned by Martin Shkreli Fined $40 Million
Vyera Pharmaceuticals, formerly headed by the now-incarcerated Martin Shkreli, was fined $40 million for dramatically spiking the price of Daraprim, [...]
IQVIA Institute Report: The Global Use of Medicines 2022
The IQVIA institute has released a report on global spending on medicines medicine during 2021 and projections up until 2026. [...]
Drug Makers Raise Prices of Hundreds of Medications by 4.9% for 2022
Data from 46Brooklyn Research shows that drugmakers have raised the cost of 460 drugs by a median of 4.9%. These [...]
Patients Rising Podcast: Healthcare Policy Changes in 2022
The landscape of upcoming healthcare policy in 2022 is the focus of the latest episode of the Patients Rising Podcast. [...]
What the European Union can Teach the US About Health Technology Assessment Harmonization
Health Technology Assessment (HTA) in the US is a convoluted piecemeal process where each payer performs their own assessments without [...]
Express Scripts Integrates Member Benefits and Rx Discount Card Pricing
Express Scripts has unveiled its new Right Price program, which lets members effortlessly get savings on prescription drugs by automatically [...]